JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (4): 30-33.doi: 10.6040/j.issn.1673-3770.0.2016.162

Previous Articles     Next Articles

Effects of interferon gamma on Eosinophil apoptosis and Eotaxin levels in nasal lavage fluid of allergic rhinitis rats.

LI Qin1, CHEN Yanlin1, MA Yanyi1, ZHANG Yongdong   

  1. 1. Department of Otorhinolaryngology, Linyi Peoples Hospital, Linyi 276003, Shandong, China;2. Department of Phamacology, Shandong Medical College, Linyi 276002, Shandong, China
  • Received:2016-04-11 Online:2016-08-16 Published:2016-08-16

PDF (PC)

853

Abstract: Objective To explore the effect of interferon gamma(IFN-γ)on the apoptosis of Eosinophils and Eotaxin levels from nasal lavage fluid in allergic rhinitis(AR)rats. Methods AR model was established by the sensitizer of ovalbumin and aluminum hydroxide. The 40 rats were randomly divided into the control group(group A, n=10), the allergic rhinitis group(group B, n=10), the budesonide group(group C, n=10)and the IFN-γ group(group D, n=10). In days 31 to 38 after the establishment of AR rats, each rat of the group D was administrated by instillation of 1 μg(1 μg/50 μL)IFN-γ into each of the nasal cavities one time a day, while each rat of the group B was administrated by instillation of 50 μL phosphate buffer in the same way, and each rat of the group C was administrated by instillation of 50 μL(1.28 μg/μL)budesonide in the same way. In days 39, the nasal lavage fluid was obtained to measure the apoptotic percentage of eosinophils and the apoptotic ratios were analyzed by flow cytometry. The levels of Eotaxin were detected by enzyme-linked immunosorbent assay(ELISA). Results The percentage of EOS in nasal lavage fluid of group C and group D was evidently lower than that of group B(all P<0.01). The eosinophil apoptotic ratio in group C and group D was evidently higher than that in group B(all P<0.01). The levels of Eotaxin in nasal lavage fluid of group C and group D were evidently lower than those in group B(all P<0.01);Furthermore significantly negative correlation was observed between the percentage of EOS and apoptotic ratio in the nasal lavage fluid of group D (r=-0.769,P<0.05). While significantly positive correlation was observed between the percentage of EOS and Eotaxin in the nasal lavage fluid of group D (r=0.750,P<0.05). Conclusion IFN-γcan significantly reduce the eosinophil infiltration and increase eosinophil apoptosis. It can reduce the levels of Eotaxin so as to achieve the purpose of treating allergic rhinitis.

Key words: Apoptosis, Nasal lavage fluid, Models, Allergic rhinitis, Eotaxin, Eosinophil, IFN-γ

CLC Number: 

  • R765.21
[1] 李钦, 张永东, 孙崇伟, 等. 鼻腔吸入γ干扰素对大鼠变应性鼻炎的治疗作用[J]. 中华耳鼻咽喉头颈外科杂志, 2008, 43(2):134-138. LI Qin, ZHANG Yongdong, SUN Chongwei, et al. Treatment of allergic rhinitis rats by intranasal interferon gamma[J]. Chin J Otorhinolaryngol Head Neck Surgery, 2008, 43(2):134-138.
[2] 李钦,李玉芬,陈彦林,等.白细胞介素5和13受体对变应性鼻炎大鼠血管细胞黏附分子1及γ干扰素的影响[J].中华耳鼻咽喉头颈外科杂志,2012,47(8):638-641. LI Qin, LI Yufen, CHEN Yanlin, et al. Effect of combined use of sIL-5Rα and sIL-13Rα2 on VCAM-1 and IFN-γ in allergic rhinitis rats[J]. Chin J Otorhinolaryngol Head Neck Surgery, 2012, 47(8):638-641.
[3] 庄晓艳,李钦,陈彦林,等. 布地奈德对变应性鼻炎大鼠鼻腔灌洗液中嗜酸性粒细胞凋亡的影响[J]. 山东大学耳鼻喉眼学报,2014,28(2):68-71. ZHUANG Xiaoyan, LI Qin, CHEN Yanlin, et al. Effects of budesonide on eosinophil apoptosis in nasal lavage fluid of allergic rhinitis rats[J]. J Otolaryngol Ophthalmol Shandong Univ, 2014, 28(2):68-71.
[4] Peric A, Vojvodic D, Vukomanovic- D-ur(-overd)evic B, et al. Eosinophilic inflammation in allergic rhinitis and nasal polyposis[J]. Arh Hig Rada Toksiko, 2011, 62(4):341-348.
[5] Cheng K J, Xu Y Y, Liu H Y, et al. Serum eosinophil cationic protein level in Chinese subjects with nonallergic and local allergic rhinitis and its relation to the severity of disease[J].Am J Rhinol Allergy, 2013, 27(1):8-12.
[6] Foresi A, Teodoro C, Leone C, et al. Eosinophil apoptosis in induced sputum from patients with seasonal allergic rhinitis and with asymptomatic and symptomatic asthma[J]. Ann Allergy Asthma Immunol, 2000, 84(4):411-416.
[7] Maskrey B H, Megson I L, Whitfield P D, et al. Mechanisms of resolution of inflammation: a focus on cardiovascular disease[J]. Arterioscler Thromb Vasc Biol, 2011, 31(5):1001-1006.
[8] Fujisawa T, Kato Y, Nagase H, et al. Chemokines induce eosinophil degranulation through CCR-3 [J]. J Allergy Clin Immunol, 2000, 106(3):507-513.
[9] Menzies-Gow A, Robinson D S. Eosinophil chemokines and chemokine receptors: their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets[J]. J Asthma, 2001, 38(8):605-613.
[10] 燕志强, 章如新, 余少卿, 等. 嗜酸细胞活化趋化因子在变应性鼻炎中的作用[J]. 中国耳鼻咽喉头颈外科杂志, 2008, 15(5):262-266. YAN Zhiqiang, ZHANG Ruxin, YU Shaoqin, et al. Role of eotaxin in allergic rhinitis[J]. Chin Arch Otolaryngol Head Neck Surgery, 2008, 15(5):262-266.
[11] Bousquet J, Khaltaev N, Cruz A A, et al. Allergic rhinitis and its impact on asthma(ARIA)2008 update(in collaboration with the World Health Organization,GA2LEN and AllerGen)[J]. Allergy, 2008, 63(1):8-160.
[12] Brozek J L, Bousquet J, Baena-Cagnani C E, et al. Allergic rhinitis and its impact on asthma(ARIA)guidelines:2010 revision[J]. J Allergy Clin Immunol,2010,126(3):466-476.
[1] LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28.
[2] GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111.
[3] QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77.
[4] DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86.
[5] XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167.
[6] XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33.
[7] HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41.
[8] LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48.
[9] YIN Zhenqian, HUANGFU Hui. Kimura disease:a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 104-107.
[10] ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147.
[11] ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134.
[12] CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50.
[13] LIU Chang, YANG Jingpu, GAO Yu, WANG Wenjia. Analysis of allergen detection results in children with allergic rhinitis in the Changchun area [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 51-58.
[14] WU Min, LI Zhengyang, MENG Jie, YE Huiping. Molecular mechanisms of programmed cell death and its role in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 152-157.
[15] ZHOU Heqing, SHEN Qi. Research progress on biomarkers of traditional Chinese medicine in the treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 168-176.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd